This consensus document provides definitions, implications, and management strategies for device-detected subclinical atrial tachyarrhythmias, highlighting their association with thromboembolic risk.
Answers are grounded in this paper and cite their sources.
Standardizes definitions and management strategies for device-detected arrhythmias; establishes a consensus framework to guide anticoagulation.
Among atrial tachyarrhythmias (AT), atrial fibrillation (AF) is the most common sustained arrhythmia. Many patients with AT have no symptoms during brief or even extended periods of the arrhythmia, making detection in patients at risk for stroke challenging. Subclinical atrial tachyarrhythmia and asymptomatic or silent atrial tachyarrhythmia often precede the development of clinical AF. Clinical AF and subclinical atrial fibrillation (SCAF) are associated with an increased risk of thromboembolism. Indeed, in many cases, SCAF is discovered only after complications such as ischaemic stroke or congestive heart failure have occurred
No takes yet. Share an insight, caveat, or question.
Görenek et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: